New potential adjuncts to treatment of children with type 1 diabetes mellitus. - Wikidata - wikimedia - TriplyDB

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

http://www.wikidata.org/entity/Q37353820

about

The evolving place of incretin-based therapies in type 2 diabetes The use of exenatide in severely burned pediatric patients.Treatment of type 2 diabetes in youth.Management of pediatric and adolescent type 2 diabetes Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.Modifiable Risk Factors for Cardiovascular Disease in Children with Type 1 Diabetes: Can Early Intervention Prevent Future Cardiovascular Events?Protective effect of cirsimaritin against streptozotocin-induced apoptosis in pancreatic beta cells.Use of Sitagliptin With Closed-Loop Technology to Decrease Postprandial Blood Glucose in Type 1 Diabetes.

P2860

Q33866808-5FDF76D1-A4A9-4234-BB56-8D05375AA3D0 Q34153353-33CE9C05-5BA2-4720-96BB-C4FCAFA4C494 Q36783749-0097B192-4F24-428B-81F0-46D19F4919C7 Q37292261-B614E36B-670D-404C-B341-8B49C4EDF845 Q37929159-6F29863A-A646-4032-BE37-B9536DDA9940 Q47159617-C33921AD-70E3-4790-8D05-AC0D216C6D37 Q48292811-54522E46-6B95-43BD-A61D-EAA210D35408 Q53396068-42F23350-9CEC-4DCF-B212-01DF473F954A

P2860

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

http://www.wikidata.org/entity/Q37353820

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@en

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@nl

type

label

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@en

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@nl

prefLabel

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@en

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@nl

P1433

Q37353820-A746EDDB-D9B7-4122-B2CF-A942F304DC55

P1476

Q37353820-F4F99D9A-7C6F-4E57-8691-DD8A2DC39C73

P2093

Q37353820-43D65C34-B2A3-40CA-9DF9-E1E9B960FA78

Q37353820-E764C2E6-7CE6-45B0-95D1-BD812B9CFF24

P2860

Q37353820-00415154-634A-4B71-AFBA-EA660E082FFF

Q37353820-08F0D957-2643-442F-AB82-CC9199DBE32C

Q37353820-0E11639A-E973-4F58-A7FE-7F13E33A7E68

Q37353820-0F0C76C3-C8BD-4798-A2DE-A175F05275B7

Q37353820-14899D76-087F-4556-B3AF-342C4AD071E3

Q37353820-26DDAF2E-347A-4587-8578-58BB41D79F98

Q37353820-28858A7E-FA2B-4821-ACDA-0EF233FBC061

Q37353820-2D3D5695-4BB3-4E54-99BD-658E2D74F4CC

Q37353820-36FCDA7A-F9A7-48EE-ADA9-C7BFBB0DDADF

Q37353820-37A777A4-EBFB-4D27-A26F-E3133B330DCA

P2888

Q37353820-889613CF-A152-418E-80E9-F33ED1969F33

P304

Q37353820-C315104D-E78C-40DF-9342-9EAD23CB0100

P31

Q37353820-0634CEF0-88F6-461C-B0E7-8A7D2D17E3BA

P356

Q37353820-10585DC3-FC4D-446C-896B-0F26481DFEF2

P407

Q37353820-50AC91BA-49CC-424E-98FC-7F3D26641F69

P433

Q37353820-342F7B87-9555-40A0-AD54-27B6074B7C6F

P478

Q37353820-02352203-224A-4D41-AF14-80357E37828A

P577

Q37353820-057ADF81-62F6-4C18-8DCF-43D4F7618784

P6179

Q37353820-CDB17066-6949-45DA-A4B9-5A8A7E039F5B

P698

Q37353820-EC5E3036-EC42-4BB9-909D-FD6E75D8C38D

P921

Q37353820-49582020-65FA-43EF-9F04-471A7D71CA05

P356

PDR.0B013E3181975EE4

P1433

Pediatric Research

P1476

New potential adjuncts to treatment of children with type 1 diabetes mellitus.

@en

P2093

Rubina A Heptulla

http://www.w3.org/2001/XMLSchema#string

Vandana S Raman

http://www.w3.org/2001/XMLSchema#string

P2860

Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients

Glucagon-like peptide 1 improved glycemic control in type 1 diabetes

Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor

Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM

Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats

Quantitative assessment of gene targeting in vitro and in vivo by the pancreatic transcription factor, Pdx1. Importance of chromatin structure in directing promoter binding.

Gut peptides and type 2 diabetes mellitus treatment.

Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level.

Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial.

Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

P2888

pdr.0b013e3181975ee4

P304

370-374

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1203/PDR.0B013E3181975EE4

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1005730621

http://www.w3.org/2001/XMLSchema#string

P698

19092720

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes